Mycology of otomycosis and the role of antifungal drops versus antifungal cream in the treatment of otomycosis: an observational study

Authors

  • V. Sneha Lekha Department of ENT, Mamata Medical College, Khammam, Telangana, India
  • Neelima Priyadarshini Department of ENT, Mamata Medical College, Khammam, Telangana, India
  • Siva Subba Rao Pakanati Department of ENT, Mamata Medical College, Khammam, Telangana, India
  • K. Dilip Kumar Department of ENT, Mamata Medical College, Khammam, Telangana, India

DOI:

https://doi.org/10.18203/issn.2454-5929.ijohns20212784

Keywords:

Otomycosis, Aspergillus, 1% clotrimazole, Drops, Cream

Abstract

Background: Aim of the study was to determine most common mode of presentation, spectrum of fungi involved in otomycosis and to compare the treatment efficacy of 1% clotrimazole drops with 1% clotrimazole cream in management of otomycosis.

Methods: A prospective observational study was conducted over a study period of 18 months, in which a total of 60 patients who are clinically diagnosed with otomycosis were included. All the specimens collected from patients were subjected to standard microbiological procedures for identification of fungi involved in otomycosis. Then patients were randomly allotted into 2 groups for treatment with 1% clotrimazole drops or with cream. Improvement in symptoms of pain, pruritis, blocked sensation, and discharge on one-and two-weeks follow-up was recorded. External auditory canal was evaluated for improvement in otomycotic debris. All patients were asked the opinion about preferred modality of treatment.

Results: In our study, Aspergillus niger 27(45%) was the predominant species isolated. When compared to the symptoms on day 01 at day 07, significant difference was noted for the improvement of the symptoms and also for the otomycotic debris in both the groups. The group with cream had significantly more blocked sensation. On second week follow up, significant improvement was noted for all the symptoms and otomycotic debris. Forty five out of sixty patients preferred using cream.

Conclusions: In our study, Aspergillus species was found to be the commonest fungi involved in otomycosis. 1% topical clotrimazole drops and cream were equally effective in management of otomycosis.

Author Biographies

V. Sneha Lekha, Department of ENT, Mamata Medical College, Khammam, Telangana, India

Post graduate

Neelima Priyadarshini, Department of ENT, Mamata Medical College, Khammam, Telangana, India

Post graduate

Siva Subba Rao Pakanati, Department of ENT, Mamata Medical College, Khammam, Telangana, India

Professor & HOD

K. Dilip Kumar, Department of ENT, Mamata Medical College, Khammam, Telangana, India

Associate Professor

References

Chander J, Maini S, Subrahmanyan S, Handa A. Otomycosis-a clinic-mycological study and efficacy of mercurochrome in its treatment. Mycopathologia. 1996;135(1):9-12.

Ho T, Vrabec JT, Yoo D, Coker NJ. Otomycosis: clinical features and treatment implications. Otolaryngol Head Neck Surg. 2006;135(5):787-91.

Mugliston T, O’Donoghue G. Otomycosis: a continuing problem. J Laryngol Otol. 1985;99(4):327-33.

Kaur R, Mittal N, Kakkar M, Aggarwal AK, Mathur MD. Otomycosis: a clinicomycologic study. Ear Nose Throat J. 2000;79(8):606-9.

Hoshino T, Matsumoto M. Otomycosis: Subdermal growth in calcified mass. Eur Arch Otorhinolaryngol. 2006;263(9):875-8.

Fasunla J, Ibekwe T, Onakoya P. Otomycosis in western Nigeria. Mycoses. 2007;51:67-70.

Jackman A. Case report topical antibiotic induced otomycosis. Int J Pediatr Otorhinolaryngol. 2005;69:957-60.

Hurst WB. Outcome of 22 cases of perforated tympanic membrane caused by otomycosis. J Laryngol Otol. 2001;115:879-80.

Pradhan B, Tuladhar NR, Amatya RM. Prevalence of otomycosis in outpatient department of otolaryngology in Tribhuvan University Teaching Hospital, Kathmandu, Nepal. Ann Otol Rhinol Laryngol. 2003;112(4):384-7.

Pradhan B, Tuladhar NR, Amatya RM. Prevalence of otomycosis in outpatient dept of otologyngology in Tribhuvan University teaching hospital, Kathmandu, Nepal. Ann Otol Rhinol Laryngol. 2003;112:384-7.

Murat Ozcan K, Ozcan M, Karaarslan A, Karaarslan F. Otomycosis in Turkey: predisposing factors, aetiology and therapy. The J Laryngol Otol. 2003;117:39-42.

Ghiacei S. Survey of Otomycosis in north-western area of Iran. Med J Mashhad Uni Med Sci. 2001;43:85-7.

Sephidgar A, Kyakajouri K, Meyrzaei M, Sharifi F. Fungal infection of external ear in otomycosis. J Babol Med Sci. 2001;13:25-9.

Anwar K, Gohar MS. Otomycosis; clinical features, predisposing factors and treatment implications. Pak J Med Sci. 2014;30(3):564-7.

Ologe FE, Nwabuisi C. Treatment outcome of otomycosis in Ilorin, Nigeria. West Afr J Med. 2002;21(1):34-6.

Abou-halawa AS, Khan MA, AlRobaee AA, Alzolibani AA, AlShobaili HA. Otomycosis with Perforated Tympanic Membrane: Self-medication with Topical Antifungal Solution versus Medicated Ear Wick. Int J Health Sci (Qassim). 2012;6(1):73-7.

Hurst WB. Outcome of 22 cases of perforated tympanic membrane caused by otomycosis. J Laryngol Otol. 2001;115(11):879-80.

Downloads

Published

2021-07-23

Issue

Section

Original Research Articles